Doctor profile · Federal record
Dr. ROBIN ISDELL
Physician Assistant · SUFFOLK, VA
- NPI 1518560655
- Accepts Medicare
- MIPS 91.8 / 100 · 2023
- 5 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5839 HARBOUR VIEW BLVD STE 200
SUFFOLK, VA 234353797
(757) 483-6100
Credentials & registration
- NPI registered
- November 2020 — 6 yrs on file
- Profile last updated
- August 3, 2021
- Year of graduation
- 2021 — 5 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Virginia #0110007980
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518560655. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
529
Distinct HCPCS
6
Medicare allowed
$55,931
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 351 | 248 | $106 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 80 | 80 | $139 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 38 | 37 | $75 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 33 | 20 | $66 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 15 | 15 | $108 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 12 | 12 | $93 |
In context: peer comparison
Among 12 peers in this city , average services per provider: 125. This provider delivers 4.2× the peer median.Open Payments
Industry payments received
All-time total
$4,973
Transactions
56
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $3,191.71 | |
| ABBVIE INC. | 20 | $1,104.66 | |
| EVOKE PHARMA, INC. | 2 | $146.15 | |
| Madrigal Pharmaceuticals | 1 | $121.97 | |
| Ardelyx, Inc. | 5 | $117.83 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81.56 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $40.55 | |
| Lilly USA, LLC | 1 | $34.86 | |
| Alnylam Pharmaceuticals Inc. | 1 | $28.32 | |
| Janssen Biotech, Inc. | 1 | $25.29 | |
| Ferring Pharmaceuticals Inc. | 1 | $24.30 | |
| Gilead Sciences, Inc. | 1 | $20.73 | |
| PFIZER INC. | 1 | $17.50 | |
| Phathom Pharmaceuticals, Inc. | 1 | $17.34 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
448
Patients
191
Total drug cost
$126,277
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Pantoprazole Sodium | Generic | 135 | 60 | $2,330 |
| Linzess (Linaclotide) | Brand | 75 | 36 | $84,330 |
| Omeprazole | Generic | 57 | 25 | $1,077 |
| Dicyclomine Hcl | Generic | 54 | 25 | $863 |
| Famotidine | Generic | 43 | 19 | $1,031 |
| Ondansetron Odt (Ondansetron) | Brand | 37 | 13 | $1,440 |
| Sucralfate | Generic | 34 | 13 | $1,377 |
| Creon (Lipase/Protease/Amylase) | Brand | 13 | 0 | $33,830 |